Evidence map›Paper›PMID 41851271›Full record

ArticleNature cell biology2026

Paraspeckle condensation is controlled via TDP-43 polymerization and linked to neuroprotection.

Rachel E Hodgson, Wan-Ping Huang, Ruaridh Lang, Vedanth Kumar, Haiyan An, Emil G P Stender, Zhaklin P Chalakova, Mark D Driver, Anna Sanchez Avila, Brittany C S Ellis and 16 more

Abstract read
In one paragraph

Article in Nature cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Rachel E Hodgson *Sheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.
Wan-Ping Huang *Sheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.
Ruaridh Lang *Sheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.
Vedanth KumarSheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.
Haiyan AnCardiff University, Cardiff, UK.
Emil G P StenderFida Biosystems ApS, Søborg, Denmark.
Zhaklin P ChalakovaSheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.
Mark D DriverZernike Institute for Advanced Materials, University of Groningen, Groningen, the Netherlands.ORCID http://orcid.org/0000-0002-8329-888X
Anna Sanchez AvilaSheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.
Brittany C S EllisSheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.
Emily DaySheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.
Jessica A RaymentSheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.
Kyungmin BaegMolecular Systems Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-9733-1839
Andrew StrangeSheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.
Tobias MollSheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.
Gareth S A WrightSchool of Life Sciences, University of Essex, Essex, UK.ORCID http://orcid.org/0000-0002-3756-9634
Joke J F A van VugtUniversity Medical Center Utrecht, Utrecht, the Netherlands.ORCID http://orcid.org/0000-0002-4161-4004
Project MinE ALS Sequencing Consortium
Scott P AllenSheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.
Nicolas LockerThe Pirbright Institute, Pirbright, Surrey, UK.
Ianthe PitoutCentre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, Western Australia, Australia.
Susan FletcherCentre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, Western Australia, Australia.ORCID http://orcid.org/0000-0002-8632-641X
Patrick R OnckZernike Institute for Advanced Materials, University of Groningen, Groningen, the Netherlands.ORCID http://orcid.org/0000-0001-5632-9727
Olivier DussMolecular Systems Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-0929-3471
Johnathan Cooper-KnockSheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0002-0873-8689
Tatyana A ShelkovnikovaSheffield Institute for Translational Neuroscience and Neuroscience Institute, University of Sheffield, Sheffield, UK. t.shelkovnikova@sheffield.ac.uk.ORCID http://orcid.org/0000-0003-1367-5309

Funding

MND Scotland (Motor Neuron Disease Scotland) PhD studentshipMotor Neurone Disease Association (MNDA) 969-799Motor Neurone Disease Association (MNDA) PhD studentshipRCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/V014110/1RCUK | Medical Research Council (MRC) MR/W028522/1Research Councils UK (RCUK) MR/W004615/1
6 · The paper itself

Abstract

The paraspeckle is a disease-relevant biomolecular condensate assembled from long non-coding RNA (lncRNA) NEAT1_2 ribonucleoprotein particles. Paraspeckle biogenesis is suppressed in normal tissues, yet it can be rapidly upregulated under stress. Here we demonstrate that a neurodegeneration-linked RNA-binding protein TDP-43 inhibits NEAT1_2 ribonucleoprotein particle condensation into the paraspeckle, in a concentration-dependent manner, which requires its intact polymerization and RNA binding. This effect is counterbalanced by core paraspeckle proteins such as FUS. Below disruptive concentrations, TDP-43 can be recruited into paraspeckles, forming non-liquid clusters. Under stress, TDP-43 sequestration into de novo nuclear condensates alleviates paraspeckle suppression and increases their dynamism. NEAT1_2 middle-part and 3'-end UG repeats mediate paraspeckle regulation by TDP-43 cotranscriptionally and post assembly, respectively. The deletion of the 3'-end UG repeat increases paraspeckle stability and cytoprotection in stressed human neurons. Consistently, longer 3'-end UG repeats are linked to shorter survival in the neurodegenerative disease amyotrophic lateral sclerosis. Thus, TDP-43 is a critical regulator of paraspeckle condensates linked to cytoprotection.

Indexed as

DNA-Binding ProteinsNeuronsNeuroprotectionRNA, Long NoncodingAmyotrophic Lateral SclerosisAnimalsBiomolecular CondensatesHumansRNA-Binding Protein FUSDNA-Binding ProteinsRNA-Binding Protein FUSRNA, Long NoncodingTARDBP protein, human

Identifiers

PMID41851271
PMCPMC13086584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.